This study is in progress, not accepting new patients
A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age
Summary
- Eligibility
- for people ages 6 months to 11 years (full criteria)
- Healthy Volunteers
- healthy people welcome
- Location
- at UCSD
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- ModernaTX, Inc.
- Links
- Click here to access the website, http://www.kidcovestudy.com, for additional information for the study, such as Study Overview, Participation, Site Locations, along with contact numbers for each location for the study.
- ID
- NCT04796896
- Phase
- Phase 2/3 research study
- Study Type
- Interventional
- Participants
- About 11950 people participating
- Last Updated